Filings (90d)
Other insiders active in the same sector
No other insider has filed at Charles Cherington's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles Cherington?
Charles Cherington is a corporate insider, tracked as 10% Owner of Ernexa Therapeutics Inc. (ERNA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Charles Cherington last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 2 filings going back to 2024.
Has Charles Cherington been buying or selling stock?
Recorded transactions: 12 open-market purchases ($2.00M) and 5 open-market sales across all tracked filings.
